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The Caenorhabditis elegans Heterochronic Regulator LIN-14 Is a
Novel Transcription Factor That Controls the Developmental
Timing of Transcription from the Insulin/Insulin-Like
Growth Factor Gene ins-33 by Direct DNA Binding
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A temporal gradient of the novel nuclear protein LIN-14 specifies the timing and sequence of stage-specific
developmental events in Caenorhabditis elegans. The profound effects of lin-14 mutations on worm development
suggest that LIN-14 directly or indirectly regulates stage-specific gene expression. We show that LIN-14 can
associate with chromatin in vivo and has in vitro DNA binding activity. A bacterially expressed C-terminal
domain of LIN-14 was used to select DNA sequences that contain a putative consensus binding site from a pool
of randomized double-stranded oligonucleotides. To identify candidates for genes directly regulated by lin-14,
we employed DNA microarray hybridization to compare the mRNA abundance of C. elegans genes in wild-type
animals to that in mutants with reduced or elevated lin-14 activity. Five of the candidate LIN-14 target genes
identified by microarrays, including the insulin/insulin-like growth factor family gene ins-33, contain putative
LIN-14 consensus sites in their upstream DNA sequences. Genetic analysis indicates that the developmental
regulation of ins-33 mRNA involves the stage-specific repression of ins-33 transcription by LIN-14 via se-
quence-specific DNA binding. These results reinforce the conclusion that lin-14 encodes a novel class of
transcription factor.
The heterochronic genes in Caenorhabditis elegans control
the expression of stage-specific developmental events (1). Dur-
ing post-embryonic development, worms go through four larval
stages (L1 through L4). Within each stage certain cells express
developmental programs specific to their cell type and specific
to the larval stage. Early during the first larval stage, the reg-
ulatory gene lin-14 specifies L1-specific development, presum-
ably by directly or indirectly promoting the expression of genes
involved in the execution of L1-specific developmental pro-
grams and/or by repressing L2-specific genes (2). The gene
lin-14 encodes a novel nuclear protein (49, 50, 59) whose levels
are high at the beginning of L1 and then rapidly decline in the
course of the first larval stage (50). This down-regulation of the
LIN-14 protein occurs as a result of translational repression by
the microRNA product of lin-4. lin-4 RNA inhibits LIN-14
protein synthesis by base pairing with complementary se-
quences in the lin-14 3 untranslated region (5, 27, 37, 60). The
reduced level of LIN-14 at the start of the L2 stage permits the
expression of L2-specific events, presumably through derepres-
sion of L2-specific gene expression (2, 3).
LIN-14 protein is localized to the nuclei of most somatic
cells in L1 larvae (50, 59), in an anatomical pattern consistent
with the cell types affected by lin-14 mutations. LIN-14 is a
novel protein that shows no obvious homology to proteins in
nonnematode species (20, 41, 59). The C terminus is sufficient
for the nuclear localization of the protein and appears to con-
tain a relatively expanded nuclear targeting signal, unlike clas-
sical nuclear localization signals (20). The only other predicted
structural motifs in LIN-14 are an amphipathic helix in the
C-terminal domain of the protein in exon 11 (59) and an alpha
helix in exon 10 (P. Olsen, personal communication). These
properties of LIN-14 have suggested that LIN-14 regulates
stage-specific gene expression in the nucleus. To gain an un-
derstanding of the possible mechanism(s) by which lin-14 helps
cells establish their temporal identity, we employed a series of
assays using the native LIN-14 protein from isolated nuclei and
bacterially expressed LIN-14 to characterize LIN-14 biochem-
ical activities. Here we show that native LIN-14 exists in at
least two populations in the nucleus, one of which is associated
with chromosomal DNA. We show that a bacterially expressed
C-terminal fragment of LIN-14 binds double-stranded DNA
and can select sequences containing a putative consensus se-
quence from a pool of randomized double-stranded oligonu-
cleotides. These results support the conclusion that LIN-14
could function as a DNA binding transcriptional regulator.
Based on lin-14 phenotypes, hypothetical lin-14 transcrip-
tional targets can be broadly divided into two classes: L2-
specific genes, which would be normally repressed by lin-14
during the L1 stage, and L1-specific genes, which would be
normally activated by lin-14 during L1. To identify candidate
LIN-14 targets, we employed DNA microarray hybridization.
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We compared mRNA abundance of 11,899 C. elegans genes in
RNA samples from the L1 and L2 stages of wild-type worms,
lin-14 loss-of-function (lf) mutants, and lin-4 loss-of-function
mutants. We identified 16 genes with characteristics of poten-
tial lin-14 targets; these genes display opposite changes in
mRNA abundance in response to reduced lin-14 [lin-14(lf)]
and elevated lin-14 [lin-4(lf)]. We confirmed that at least one of
these genes, ins-33, is a bona fide transcriptional target of
LIN-14; ins-33 promoter activity is temporally regulated by
lin-14 in vivo, and LIN-14 binds in vitro to ins-33 upstream
sequences that are essential for negative developmental regu-
lation by lin-14. These results demonstrate that lin-14 encodes
a novel class of transcription factor that controls developmen-
tal timing via direct DNA binding.
MATERIALS AND METHODS
Worm strains. C. elegans (wild type strain N2 var Bristol) was cultured on
NGM plates or in liquid culture as previously described (61), at 20°C unless
otherwise noted. Synchronized populations of wild-type or mutant larvae were
obtained by hypochlorite treatment of gravid adults, allowing embryos to develop
to hatching in the absence of food, followed by growth of the L1 larvae on NGM
plates with food (bacterial strain OP-50). To obtain lin-14 mutant L1 popula-
tions, VT965 [lin-14(n179ts)] starved L1 larvae were placed on NGM plates
seeded with bacteria and grown at the nonpermissive temperature (25°C) for 7
to 8 h before harvesting. lin-4 L1 larvae were grown on food for 21 to 22 h at 20°C
to obtain L2 larvae. All worm populations were harvested by washing the plates
with ice-cold distilled water (dH2O) and rinsed three times with cold dH2O
before being snap-frozen in liquid N2.
Nuclear isolation. Nuclei from L1 larvae were isolated as described (29) except
that worms were homogenized in buffer A (250 mM sucrose, 10 mM Tris-HCl,
pH 8.0, 10 mM MgCl2, 1 mM EGTA, 1 mM DTT, 2 g/ml aprotinin, 1 g/ml
leupeptin, 1 g/ml pepstatin A, 2 mM Pefabloc). Nuclei were stored at 80°C in
10% glycerol and buffer B (buffer A plus 60 mM KCl, 15 mM NaCl, 15 mM
Tris-HCl, pH 7.4, 3 mM MgCl2, 2 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml
pepstatin A, 2 mM Pefabloc) (13). Nuclear DNA concentration was estimated by
optical density at 260 nm of an aliquot in 1% sodium dodecyl sulfate (SDS).
MNase assay. Nuclei were thawed on ice and recovered by centrifugation in a
refrigerated microcentrifuge at 11,500 rpm for 10 min. Nuclei were resuspended
in micrococcal nuclease (MNase) buffer (10 mM HEPES, 10 mM KCl, 0.5 mM
MgCl2, 2 mM CaCl2, 2 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin A,
2 mM Pefabloc) to a DNA concentration of 1 g/l (10). MNase (Worthington
Biochemical) was added at concentrations from 10 to 150 units/100 g DNA, and
the nuclei were incubated on ice for 35 to 45 min. Digestion was stopped by the
addition of an equal volume of MNase buffer supplemented with 10 mM EDTA.
After a 10-min spin at 4,000 rpm in a refrigerated microcentrifuge, the super-
natant was either loaded onto a sucrose gradient (see below) or subjected to
centrifugation at 100,000  g for 1 h in a Beckman tabletop ultracentrifuge
(adapted from Liang and Stillman [28]). For RNase digestion, DNase-free
RNase A (Sigma) was used under the same incubation conditions as those for
MNase, and the digestion of RNA was verified by agarose gel electrophoresis
after RNA isolation using Trizol (GibcoBRL).
For sucrose gradient analysis, 5 ml of 20 to 40% sucrose gradients in MNase
stop buffer was centrifuged for 3.25 h at 40,000 rpm in a Beckman ultracentrifuge
(SW 55 Ti rotor). Fractions (275 l each) were collected by hand and split;
two-thirds of each fraction was precipitated with trichloroacetic acid and resus-
pended in SDS-polyacrylamide gel electrophoresis (PAGE) loading buffer, while
one-third was phenol extracted and ethanol precipitated to recover DNA.
Nuclear matrix assays. (i) High salt procedure. Nuclei were thawed on ice and
recovered by centrifugation at 4°C and 11,500 rpm for 10 min in a refrigerated
microcentrifuge. Nuclear matrix was prepared from the pelleted nuclei according
to published protocols (16, 43). As a control, high-salt-extracted pellets were
digested with DNase-free RNase A (Sigma).
(ii) Low-salt procedure. For the low-salt procedure, adapted from Smith et al.
(53) and Mirkovitch et al. (35), nuclei were thawed on ice and recovered by
centrifugation for 10 min at 4°C, 11,500 rpm, in a microcentrifuge. Nuclei were
resuspended in low-salt buffer (5 mM HEPES, pH 7.9, 2 mM EDTA, 2 mM KCl,
0.25 mM spermidine, 2 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin A,
2 mM Pefabloc) at a DNA concentration of 2 g/l and incubated at room
temperature for 15 min. (As a control, in at least one experiment the nuclei were
pelleted after this step to analyze the effect of low-salt buffer alone on nuclear
protein release). An equal amount of low-salt buffer supplemented with lithium
3,5-diiodosalicylate to 50 mM was added to the nuclei to a final lithium 3,5-
diiodosalicylate concentration of 25 mM, and the nuclei were incubated for
another 5 min at 22°C. Extracted nuclei were recovered by centrifugation at
5,000  g for 3 min at 22°C and washed three times in buffer containing 20 mM
Tris, pH 7.4, 20 mM KCl, 70 mM NaCl, 0.5 mM spermine, 0.125 mM spermidine,
2 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin A, 2 mM Pefabloc.
Nuclei were resuspended in wash buffer and incubated with RNase-free DNase
I (Boehringer Mannheim) at 0.5 U/g DNA for 15 min at 37°C. After a final
3-min 5,000  g spin, the nuclear matrix was resuspended in 8 M urea.
LIN-14 fusion protein expression and purification. LIN-14 coding sequences
were amplified from a plasmid containing lin-14 cDNA and were cloned into the
glutathione transferase (GST) expression vector pGEX-2T (GE Healthcare) to
create a fusion protein with the GST module at the N terminus of the fusion
protein. Primers were chosen to amplify sequences coding amino acids 292 to
539 or amino acids 284 to 465 [in the case of GST::LIN-14(292–539) or
GST::LIN-14(284–465), respectively] (Fig. 1A). Purification of the GST fusion
proteins was carried out as previously described (14), except that cells were lysed
by sonication, sarcosyl was omitted from the buffer, and an additional clarifying
spin step was carried out at 100,000  g. Protein bound to glutathione-Sepharose
beads (GE Healthcare) was either frozen as a 50% bead slurry in 10% glycerol,
50 mM HEPES, pH 7.9, 150 mM NaCl, and 5 mM dithiothreitol (DTT) or eluted
from the beads in the above buffer supplemented with 15 mM glutathione.
Elution fractions containing the fusion protein were stored at 80°C. Amino
acids 284 to 465 were fused to a six-His tag by PCR amplification with appro-
priate primers, and the His-tagged fusion protein was purified from Escherichia
coli by metal affinity resin. Protein fractions were analyzed using 11% SDS-
PAGE gels, and proteins were visualized by Coomassie blue staining.
DNA binding of GST::LIN-14(284–465). DNA cellulose binding was per-
formed using Sigma brand cellulose coupled to double-stranded or single-
stranded DNA (D8515 or D8273). Bacterially expressed GST::LIN-14(284–465)
fusion protein was diluted in 75 mM NaCl, 50 mM HEPES, 7.5 mM glutathione,
5% glycerol, 2.5 mM, and 0.1 mM EDTA and bound in batch to DNA-cellulose
by rocking at 4°C for 1.5 h. The protein-DNA-cellulose complexes were recov-
ered by centrifugation in a clinical centrifuge and washed three to four times with
10 column volumes each of cold wash buffer (150 mM NaCl, 50 mM HEPES, 0.1
mM EDTA, 0.5 mM DTT). Protein was eluted with 3 to 6 column volumes of
elution buffer (50 mM HEPES, 0.5 mM DTT, 0.1 mM EDTA, 0.005% Triton
X-100) supplemented with increasing concentrations of NaCl (200 mM, 400 mM,
800 mM, and 1.5 M). Equivalent amounts of each fraction were analyzed on
SDS-PAGE gels.
Binding site selection assay (SELEX). DNA sequences for consensus site
selection were generated from the following oligonucleotide input sequence:
5 AGA GGG ATC CGA TTG CAG-N20-GTG TAG GAA TTC GCC GTG 3
(PO66), where the middle 20 bases (N20) were randomized during synthesis.
These sequences have BamHI and EcoRI restriction sites (underlined) in the
5 and 3 ends, respectively, for subsequent cloning. Two PCR primers comple-
mentary to the 5 and 3 constant regions were also synthesized (PO67 and
PO68). Double-stranded oligonucleotides were synthesized from the PO66 pool
by extension with Klenow (NEB) using primer PO68.
Binding reactions were performed in a 250-l volume for 30 min at 4°C
(adapted from Chittenden et al. [11]). Twenty microliters of frozen glutathione-
Sepharose beads complexed with GST::LIN-14(284–465) was diluted in binding
buffer (50 mM HEPES, 100 mM NaCl, 2 mM MgCl2, 0.5 mM EDTA, 5 mM
DTT, 10% glycerol, 100 ng/ml) containing double-stranded oligonucleotides.
After incubation, the beads were washed three to four times with 1 ml of cold
binding buffer to eliminate unbound DNA. Elution of DNA bound to the im-
mobilized protein was carried out as described (7). Approximately 10% of the
recovered DNA was amplified via PCR to prepare DNA for the next round of
binding.
Amplification conditions were optimized and the following protocol was used:
95°C for 5 min and then 19 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for
140 s, with a final step of 72°C for 5 min. After the fourth and fifth rounds of
selection, oligonucleotide pools were digested with EcoRI and BamHI and
cloned in Bluescript SK vector. Colonies with inserts were selected by blue/white
selection and sequenced using a T7 primer. Most colonies contained multiple
concatamerized independent inserts. The randomized sequences were compared
and aligned manually.
EMSAs. Probes were end labeled with 32P and T4 polynucleotide kinase, and
approximately 20 fmol of labeled probe was added to each binding reaction
(2 nM final concentration). Electrophoretic mobility shift assays (EMSAs) were
performed essentially as described (7). Binding reactions were performed in
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binding buffer (50 mM HEPES, pH 7.9, 100 mM NaCl, 2 mM MgCl2, 1 mM
DTT, 10% glycerol, dI-dC at 0.02 g/l final concentration, bovine serum albu-
min at a final concentration of 1 g/l) for 20 min at room temperature. A fusion
protein consisting of a six-His-tagged version of LIN-14 containing amino acids
284 to 465 [6HIS::LIN-14(284–465)] was included in the binding reaction at
concentrations of 8 nM to 320 nM.
Binding reactions were fractionated by electrophoresis in 3.5% or 4% (acryl-
amide/bisacrylamide ratio of 60:1) nondenaturing polyacrylamide gels. All gels
were run at 4°C at 30 to 35 mA for 1.5 to 3 h in 0.5 Tris-borate-EDTA. Gels
were exposed to a storage phosphor screen and images were captured on a
Typhoon 8600 Variable Mode Imager using the ImageQuant Software (Molec-
ular Dynamics). Images were further processed using Adobe Photoshop.
DNase I footprinting. The binding reaction for the DNase I footprinting
analysis was carried out using the same reaction conditions as for EMSA except
that protein [6HIS::LIN-14(284–465)] was added in molar excess to probe at
quantities sufficient to retard all of the free probe in EMSA experiments. DNase
I (Boehringer Mannheim) was then added to the binding reactions at a concen-
tration of 0.01 U/ng of radiolabeled DNA probe, and the reaction mixtures were
incubated for 5 min at room temperature. Digestion was stopped by the addition
of an EDTA/EGTA cocktail to a final concentration of 2 mM each, and the
samples were heated at 65°C for 10 min, dialyzed against dH2O, lyophilized in a
Speedvac, and then resuspended in denaturing loading buffer. Samples were then
heated and fractionated by electrophoresis through a 6% urea acrylamide gel
(SequaGel; National Diagnostics) in 0.5 or 1 Tris-borate-EDTA buffer at
55°C for approximately 1 to 3 h. After drying, gels were exposed to a storage
phosphor screen, and images were captured and processed as described above.
Western blots. Western blot analysis was performed according to standard
procedures (7) using Renaissance Enhanced Luminol Chemiluminescence Re-
agent (New England Nuclear). Proteins were transferred onto Millipore brand
Immobilon-P membranes. Primary antibody incubations were performed in 1
phosphate-buffered saline supplemented with 5% nonfat dry milk for 1 to 2 h at
room temperature or at 4°C overnight. LIN-14 antisera were generated (Covance
Research Products, Inc.) against 6HIS::LIN-14(284–465) (Fig. 1A). Antisera
were affinity purified using purified GST::LIN-14(292–539) (Fig. 1A) according
to established procedures (18) using cyanogen bromide-activated Sepharose
(Amersham Pharmacia Biotech). Whenever reprobing of membranes was nec-
essary, blots were stripped by incubating at 68°C for 30 min in 100 mM Tris, pH
7.4, 100 mM -mercaptoethanol, and 2% SDS.
Commercially available monoclonal antibodies were used to detect core his-
tones and H1 (Chemicon International). Anti-green fluorescent protein (GFP)
antibodies were purchased from Clonetech (Living Colors A.V.). Donkey anti-
rabbit horseradish peroxidase-conjugated secondary antibodies were obtained
from Amersham Life Sciences. Monoclonal antisera against C. elegans-TATA
binding protein were kindly provided by N. Hernandez (48). Polyclonal antisera
against C. elegans-lamin (lmn-1) were generously provided by Y. Gruenbaum
(26, 45). Polyclonal antisera against LIN-26 were a gift from M. Labouesse (25).
RNA isolation and mRNA purification. Total worm RNA was isolated using
Trizol (GibcoBRL) as follows. Frozen worm pellets were thawed in the presence
of 4 volumes of Trizol and vortexed for 10 min; the mixture was spun at 14,000
rpm for 10 min at 4°C, and the supernatant was removed to a fresh tube, to which
one-fifth volume CHCl3 was added; the mixture was vortexed and centrifuged for
15 min at 14,000 rpm at 4°C. The aqueous phase was removed to a new tube, and
the RNA was precipitated by the addition of an equal volume of isopropanol.
RNA samples were stored at 80°C as an ethanol precipitate. mRNA was
prepared from total worm RNA using oligo(dT) cellulose (Sigma) and following
published procedures (51). mRNA samples were shipped as dried pellets on
FIG. 1. Chromatin association of LIN-14::GFP fusion proteins in vivo. (A) Schematic representation of the different truncated versions of
LIN-14 used in chromosome association experiments (GFP fusions designated D3 and D5 to D10 [20]) and in DNA binding experiments (GST
and six-His fusions). The n179 mutation in exon 9 of D10 is indicated by an asterisk. GST::LIN-14(292–539) contains LIN-14 amino acids 292 to
539, which comprise exons 9 to 13, identical to the fragment included in LIN-14D5::GFP. GST::LIN-14(284–465) and 6HIS::LIN-14(284–465)
contain LIN-14 amino acids 284 to 465, identical to the fragment included in LIN-14D9::GFP. Exon numbers are indicated above the constructs.
All images are of lin-14(n179) animals carrying transgenic LIN-14 constructs, except for the image in panel C, which is lin-14(ma135). Arrows
indicate the mitotic chromosomes. (B to D) Rescuing truncated LIN-14::GFP proteins associate with mitotic chromosomes: LIN-14D5::GFP in
lin-14(n179) (B) and lin-14(ma135) backgrounds (C); LIN-14D9::GFP (D). (E to G) Nonrescuing truncated LIN-14::GFP proteins do not associate
with mitotic chromosomes: LIN-14D6::GFP (E), LIN-14D7::GFP (F), LIN-14D8::GFP (G). Scale bar, 1.5 m.
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dry ice to Stuart Kim’s laboratory at Stanford University for cDNA synthesis
and microarray hybridization (procedures available at http://cmgm.stanford.edu
/kimlab/wmdirectorybig.html).
Microarray data and statistics. The data from six experiments [three repeats
of N2 L1s versus lin-14(n179ts) L1s and three repeats of N2 L2 larvae versus
lin-4(e912) L2 larvae] are stored on the Stanford Microarray Database (http:
//genome-www4.stanford.edu/cgi-bin/SMD/login.pl; the identifier is “experi-
menter: MHRISTOVA”). The first three experiments (N2 versus lin-14) were
performed using microarrays containing 63% of predicted C. elegans open read-
ing frames (42), while the second three experiments (N2 versus lin-4) were
performed using microarrays containing 94% of predicted open reading frames
(22). For the purposes of this paper, only the genes that were analyzed in all six
experiments will be discussed.
Raw data from each experiment were downloaded from the Stanford Microar-
ray Database into Excel files and processed as follows: (i) sort by Spot Flag and
discard any rows where the Spot Flag value was nonzero, indicating a bad PCR;
(ii) sort by Failed and discard any rows where the Failed value was nonzero,
indicating abnormal hybridization; (iii) import into a common file for each type
of experiment (i.e., lin-14 or lin-4) the columns from each raw experimental file
[RAT2(R/G), which shows a log base 2 transformed ratio of normalized red/
green signal for each spot; name of spot (Wormbase designation); chromosome
location and description (www.wormbase.org)]; (iv) calculate an average
RAT2(R/G) based on the 2 or 3 values (avg; any rows which had only one good
experimental value were discarded); (v) calculate a standard deviation (stdev) for
the average value; (vi) calculate a t value for each spot by using the formula t 
avg*[sqrt(n 1)]/stdev, where n is the number of experiments for which good
data exist, sqrt is square root, and stdev is standard deviation; (vii) sort by
absolute t value and discard any rows with a t value below 4.303 (below 95%
confidence interval for three experiments) or below 12.706 (below 95% confi-
dence interval for two experiments); (viii) sort by absolute average value and
discard any rows with average values below 1.0 (less than twofold change com-
pared to control).
Northern blot hybridization. Northern blot hybridization using the formalde-
hyde method of gel electrophoresis was performed on poly(A)-selected RNA
following established procedures (7). After exposure to a storage phosphor
screen, images were captured on a Typhoon 8600 Variable Mode Imager using
the ImageQuant Software (Molecular Dynamics). Images were subsequently
processed using Adobe Photoshop.
Reporter fusions. A 2.0-kb fragment of the ins-33 promoter was amplified and
cloned into the GFP expression vector pPD95.67 containing a nuclear targeting
signal (13a) to generate the ins-33::GFP vector pVT396. Subsequently, a version
of this vector containing only 452 bp of the ins-33 upstream region (for sequence,
see Fig. S3 available at http://banjo.dartmouth.edu/Hristova_etal_Sup/) was gen-
erated (pVT397) by removing intervening sequences of the promoter by diges-
tion using an internal ClaI site and the HindIII pPD95.67 cloning site. To
introduce mutations at putative LIN-14 binding sites within the 452-bp fragment,
PCR using oligonucleotides with the mutations was carried out, and the new
sequence verified by sequencing.
Germ line transformation and analysis of GFP reporter expression. Worms
were transformed by microinjection as previously described (34). Transgenes
expressing various regions of LIN-14 protein fused to GFP were previously
described (20). The construct carrying the lin-14(ma135) loss-of-function allele
was generated by PCR from genomic DNA from mutant animals. The mutation
was verified by sequencing. The transgenic strains were generated by microin-
jection of purified plasmid DNA to a concentration of 20 ng/l, DraI-digested N2
genomic DNA to a concentration of 100 ng/l, and pVT301 (col-19::GFP) to a
concentration of 15 ng/l as a coinjection marker (extrachromosomal array
maEx177). The following extrachromosomal arrays were generated: maEx171
(plasmid pVT396), maEx172 (plasmid pVT397), and maEx173 (plasmid
pVT397mut). Expression of GFP reporters in live transgenic worms was char-
acterized using a Zeiss Axioscop fluorescence microscope. Worms were anes-
thetized using 1 mM levamisole, and images were captured using an Optronics
DEI750 integrating color charge-coupled-device video camera and a Scion CG-7
RGB video capture board on a Power Macintosh G4. Images were further
processed using Adobe Photoshop.
RNAi. RNA-mediated interference (RNAi) was performed as previously de-
scribed (15, 56) except that the isopropyl--D-thiogalactopyranoside concentra-
tion in the NGM plates was 5 mM. To make the ins-33 RNAi vector, the coding
region of ins-33, including a kilobase of intronic sequence, was amplified and
cloned into the feeding vector L4440 (56). Ten L4 or young adult worms were
placed onto a plate seeded with the bacterial strain HT115 expressing the RNAi
plasmid of interest. After 24 to 30 h, the adults were removed, and progeny were
scored 16 to 18 h later for viability and visible phenotypes.
RESULTS
Low-affinity nuclear association and chromosome binding
of LIN-14 correlate with lin-14 function in vivo. The analysis of
nuclei from worm extracts reveals three types of interactions
between endogenous LIN-14 and worm nuclei: (i) a LIN-14
fraction that elutes easily with the low-salt buffer used to pre-
pare nuclei (Table 1; see Fig. S1 available at http://banjo
.dartmouth.edu/Hristova_etal_Sup/); (ii) a LIN-14 fraction that
elutes with nuclease treatment, suggesting chromosomal asso-
ciation of this fraction (see Fig. S1 at http://banjo.dartmouth
.edu/Hristova_etal_Sup/); and (iii) a tightly bound LIN-14 frac-
tion that appears to be associated with the nuclear matrix
(Table 1; see Fig. S2 at http://banjo.dartmouth.edu/Hristova
_etal_Sup/). Our results described below suggest that lin-14
function in vivo does not require the tight binding of LIN-14 to
the nuclear matrix; rather, lin-14 function seems to be associ-
ated with the chromosome binding activity of LIN-14.
To investigate which domains of LIN-14 mediate the low-
affinity and high-affinity nuclear association properties of the
protein and which of these properties of LIN-14 best correlates
with lin-14 function in vivo, we examined the nuclear associa-
tion of various LIN-14::GFP fusion proteins. Nuclei were iso-
lated from transgenic worms carrying extrachromosomal arrays
expressing N-terminally truncated forms of LIN-14 fused to
GFP (Fig. 1A) (20). The behavior of two of these constructs,
LIN-14D5::GFP (exons 9 to 13) and LIN-14D6::GFP (exons
10 to 13), in cell fractionation experiments is summarized in
Table 1. Previously, the in vivo nuclear localization of both
TABLE 1. In vitro nuclear association and in vivo activity of lin-14 deletion constructs






Endogenous LIN-14 1–13  60%  
lin-14(n179); LIN-14D5::GFP 9–13  0% NA 
lin-14(n179); LIN-14D6::GFP 10–13  0% NA
a Transgenic animals were homozygous mutant for lin-14(n179ts) and also contain an extrachromosomal array carrying the indicated LIN-14 deletion construct.
(Fig. 1A) (see reference 20 for details).
b Native protein localization was determined by indirect immunofluorescence (50) using anti-LIN-14 antibodies (data not shown). Localization of the GFP fusion
proteins was determined by microscopy. , exclusively nuclear localization; , predominantly nuclear localization; , about two-thirds nuclear localization.
c Estimated portion of the LIN-14 protein in the pellet versus supernatant fractions, as determined Western blotting, after low-salt lysis of L1 larvae.
d Presence of LIN-14 retained in nuclei after low-salt wash, and extractable with nuclear matrix in lithium 3,5-diiodosalicylate wash. Matrix association assays were
not performed, because negligible amounts of LIN-14D5::GFP or LIN-14D6::GFP remained associated with the nuclear fraction after low salt extraction.
e See Table 2.
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LIN-14D5::GFP and LIN-14D6::GFP was verified by micros-
copy, and LIN-14D5::GFP was found to be functional in vivo,
while LIN-14D6::GFP was not functional (20). Significantly,
we found that essentially all LIN-14D5::GFP and LIN-14D6::GFP
was easily extracted from nuclei with low salt, indicating that
neither fusion protein associates with the nuclear matrix. Since
both constructs are nuclear localized in vivo (20) and since
LIN-14D5::GFP rescues lin-14 activity, we conclude that nu-
clear matrix association is not critical for LIN-14 nuclear lo-
calization or for lin-14 function in vivo.
Among a set of truncated LIN-14::GFP fusion proteins that
we tested in transgenic worms, lin-14 rescuing activity corre-
lated precisely with chromosome association, as revealed dur-
ing mitotic chromosome condensation (Fig. 1; Table 2). In
transgenic worms expressing truncated versions of LIN-14
fused to GFP, fluorescence was diffusely distributed within
interphase nuclei, but during mitosis, fluorescence becomes
concentrated in association with mitotic chromosomes (20)
(Fig. 1B to D). For example, in Fig. 1B and C, LIN-14D5::GFP
fluorescence can be seen in association with mitotic chromo-
somes. LIN-14D5::GFP displayed mitotic chromosome associ-
ation in lin-14(null) animals (Fig. 1C and Table 2), indicating
that endogenous lin-14 activity is not required for the chroma-
tin association of a LIN-14::GFP fusion protein.
The nonrescuing construct, LIN-14D10::GFP, which con-
tains exons 9 to 13 with the n179 point mutation, did not
associate with either metaphase or anaphase chromosomes
(Table 2), even though the mutant protein’s nuclear localiza-
tion appears to be normal before and after mitosis (data not
shown). Other nonrescuing constructs, LIN-14D6::GFP, LIN-
14D7::GFP, and LIN-14D8::GFP, also showed no chromo-
somal association (Fig. 1E to G and Table 2), suggesting that
the ability to associate with mitotic chromosomes reflects an
activity of LIN-14 that is related to its in vivo function. It
should be noted that endogenous LIN-14, assayed by immu-
nohistochemistry, was not detectable in association with mi-
totic chromosomes (data not shown). Thus, endogenous
LIN-14 may associate with mitotic chromosomes in amounts
below the sensitivity of the LIN-14 antiserum. Since the trun-
cated LIN-14 fusion proteins (which are produced from extra-
chromosomal arrays) are expressed at levels that likely exceed
that of endogenous LIN-14, their behavior may reflect a nat-
ural, low-affinity chromosome binding activity of LIN-14. It is
nevertheless possible that the chromosome association exhib-
ited by truncated LIN-14::GFP proteins is chiefly a result of
the removal of carboxy-terminal domains of LIN-14.
Bacterially expressed LIN-14 protein can bind DNA. To
explore further the biochemical activity of LIN-14, we generated
a GST-tagged LIN-14 fusion protein [GST::LIN-14(244–465)]
containing the LIN-14 sequences from the D9-GFP construct
(Fig. 1A). D9 had previously been shown by Hong et al. (20)
to be sufficient for lin-14 activity in vivo (Table 2). The
GST module at the N terminus of the protein was used to
purify GST::LIN-14(244–465) using glutathione beads (GE
Healthcare) (14).
To investigate whether LIN-14 can bind nucleic acids, puri-
fied GST::LIN-14(244–465) was applied to a double-stranded
DNA cellulose column in low salt (50 to 75 mM NaCl), the
column was washed with 150 mM NaCl, and bound protein was
eluted step-wise with increasing concentrations of NaCl (Fig. 2A).
Eluted fractions were collected and run on an 11% SDS-
FIG. 2. DNA binding activity of bacterially expressed LIN-14.
(A) Purified bacterially expressed LIN-14::GST was applied to double-
stranded DNA-cellulose, and the bound and eluted fractions were
analyzed by SDS gel electrophoresis and Coomassie staining. M, mo-
lecular weight markers; lane 1, sample of material prior to loading on
DNA cellulose; lane 2, flowthrough; lane 3, wash with loading buffer;
lanes 4 to 7, elution with 200 mM NaCl, 400 mM NaCl, 800 mM NaCl,
and 1.5 M NaCl, respectively. Three elution fractions were collected
for each NaCl concentration, pooled, and dialyzed against 150 mM
NaCl, and a sample of the dialyzed protein was loaded onto the gel.
(B) Sequence logo of SELEX-derived consensus binding specificity of
bacterially expressed LIN-14, generated using WebLogo (http:
//weblogo.berkeley.edu) from 162 sequences (see Tables S3 and S4 at
http://banjo.dartmouth.edu/Hristova_etal_Sup/).
TABLE 2. In vivo chromosome association and genetic






lin-14(n179); LIN-14D3::GFP 5–8*  
lin-14(n179); LIN-14D5::GFP 9–13  
lin-14(ma135); LIN-14D5::GFP 9–13  
lin-14(n179); LIN-14D6::GFP 10–13  
lin-14(n179); LIN-14D7::GFP 11–13  
lin-14(n179); LIN-14D8::GFP 9–11*  
lin-14(n179); LIN-14D9::GFP 8*–12*  
lin-14(n179); LIN-14D10::GFP 9(n179)–13  
a Transgenic animals were homozygous mutant for either lin-14(n179ts) or for
lin-14(ma135) and also contain an extrachromosomal array carrying the indi-
cated LIN-14 deletion construct (Fig 1) (20).
b See Hong et al. (20) for details of constructs. Asterisks indicate that the
construct does not contain the full-length exon.
c , chromosome association observed; , no chromosome association ev-
ident.
d Summary of transgenic rescue results from Hong et al. (20). , relatively
strong rescue;  relatively weaker rescue; , no rescue.
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PAGE gel. The fusion protein bound to DNA and was eluted
with 400 mM salt, a concentration typical of other DNA-bind-
ing proteins (Fig. 2A, lane 5) (55). The fusion protein can also
bind single-stranded DNA and elutes at similar salt concentra-
tions (data not shown). A similar LIN-14 fusion protein tagged
with a six-histidine element [Fig. 1A, 6HIS::LIN-14(244–465)]
also showed similar affinity to double-stranded DNA (data not
shown), indicating that the LIN-14 moiety is responsible for
the in vitro DNA-binding activity of these fusion proteins.
Bacterially expressed LIN-14 can select a double-stranded
DNA consensus binding site from random double-stranded
oligonucleotides. To determine if LIN-14 prefers a specific
DNA sequence, we performed a PCR-based selection assay to
screen for consensus binding sites. Starting with double-
stranded oligonucleotides that contained random stretches of
20 nucleotides, we performed five rounds of selection and
amplification of oligonucleotides bound to GST::LIN-14(244–
465). Glutathione beads were used to pellet and wash the
protein-DNA complex. The bound DNA was eluted and used
as a template for further PCR amplification (see Materials and
Methods).
Overall, 188 sequences were recovered from rounds 4 and 5
of the selection process. A total of 163 of these sequences were
manually aligned by their core consensus GAAC, which was
identified after visual inspection. The results of these sequence
alignments (Fig. 2B) (see also Tables S1 and S2 at http://banjo
.dartmouth.edu/Hristova_etal_Sup/) suggest a LIN-14 consensus
binding sequence GAACRY (complement, RYGTTC).
Genes affected in mRNA abundance in lin-4(lf) and lin-14(lf)
mutants. To identify candidate LIN-14 target genes whose
transcription would be repressed or activated by lin-14 in the
L1 stage, we performed microarray analysis of C. elegans tran-
script levels at the L1 and L2 stages in RNA prepared from
synchronized populations of wild type, lin-14(lf), and lin-4(lf)
larvae. The results from two complementary sets of microarray
experiments are summarized in Table 3. Of the 11,899 genes
assayed, 463 (classes A to D, G, and H) showed at least a
twofold statistically significant change in expression in lin-14(lf)
mutants compared to wild-type animals; of those 463 lin-14-
responsive genes, 311 genes (classes B, D, and H) were ele-
vated in the absence of lin-14, and 152 genes (classes A, C, and
G) were reduced. A total of 442 genes (classes C to H) showed
at least a twofold statistically significant change in expression in
lin-4(lf) mutants compared to wild-type animals; of the 442
lin-4-responsive genes, 334 genes (classes C, E, and H) were
elevated in the absence of lin-4, and 108 genes (classes D, F,
and G) were reduced. Twenty-one genes (classes C, D, G, and
H) were affected in both lin-14(lf) and lin-4(lf) mutants.
Candidate LIN-14 direct targets. The objective of our ex-
pression profiling of lin-14 and lin-4 larval stages was to iden-
tify candidate direct targets of lin-14 so that these could be
used to test the hypothesis that LIN-14 is a novel transcription
factor. The best candidates for lin-14 target genes would be
genes whose mRNA levels changed in a complementary fash-
ion in lin-14 and lin-4 mutants. In particular, genes of class D,
which were elevated in the lin-14(lf) mutant and reduced in the
lin-4(lf) mutant, would be potential L2-specific lin-14 targets
that are normally repressed by lin-14 during the L1 stage, while
genes of class C, which are reduced in lin-14(lf) mutant worms
and elevated in the lin-4(lf) mutant worms, would be potential
L1-specific targets that are normally activated by lin-14 during
the L1 stage (Table 3). Sixteen genes fit these criteria (Table 3),
including 5 genes of the L2-specific category (class D) and 11
genes of the L1-specific category (class C).
Although any of the 16 class C and class D genes could be
direct targets of LIN-14, we applied further criteria to narrow
the set of candidates. First, we compared the list of 16 candi-
dates to published microarray gene expression data that ana-
lyzed mRNA levels in RNA from C. elegans larval stages (19).
Four of the class C genes (F41C3.5, C50F2.6, W01F3.3, and
C44H4.3) were found to be more abundant in L1 larvae than
in L2 larvae in a study by Hill et al. (19) (Table 4). This is
consistent with our results that these four genes are reduced in
mRNA abundance in lin-14(lf) L1 larvae compared to wild
type, and hence could be L1-enriched genes that are normally
under positive temporal regulation by LIN-14. One of the class
D genes (W09C5.4) was detected at a higher level in L2 larvae
than in L1 larvae by Hill et al. (19), which is consistent with our
finding that W09C5.4 is elevated in lin-14(lf) L1 larvae com-
pared to the wild type, and hence could be an L2-enriched
gene that is normally under negative temporal regulation by
LIN-14.
As a final criterion for identifying candidate target genes
that LIN-14 could regulate in vivo by DNA binding, we exam-
ined the upstream sequences (within 4,000 bp of the start of
translation) of the genes in Table 4 for occurrence of se-
quences that fit the consensus LIN-14 binding sequence gen-
erated by SELEX analysis (Fig. 2B; see Table S3 at http://banjo
.dartmouth.edu/Hristova_etal_Sup/). For this analysis we used
an expanded consensus sequence including a total of 12 bases
surrounding the GAACRY core (derived from alignment of
the sequences in Table S1 at http://banjo.dartmouth.edu
/Hristova_etal_Sup/), followed by processing using the
CisOrtho software pipeline (http://wormbase.org/cisortho/)
TABLE 3. Effects of lin-14(lf) and lin-4 (lf) mutations
on C. elegans mRNA levels
Classa
Effect on mRNA level
No. of genesb
lin-14(lf) in L1 lin-4(lf) in L2
A Down No change 137
B Up No change 305
C Down Up 11
D Up Down 5
E No change Up 322
F No change Down 99
G Down Down 4
H Up Up 1
I No change No change 11,015
a Classes of genes observed by microarray hybridization, based on at least a
twofold change in transcript levels in lin-4 and lin-14 mutants compared to the
wild-type. Eight different behaviors were observed (corresponding to classes A to
H). Genes of class A and B are affected by lin-14(lf) but not lin-4(lf), suggesting
that their transcript levels are controlled by lin-14 in the L1 stage only. Genes of
class C and D are affected in opposite ways by lin-14(lf) and lin-4(lf), suggesting
that their transcription could be regulated by lin-14 in L1, and by lin-4 in L2 via
repression of lin-14. Genes of classes E and F are affected by lin-4(lf) but not by
lin-14(lf), suggesting these genes are regulated independently of lin-14 in L1 and
by lin-4 in L2 via repression of a putative unknown lin-4 target. Genes of class G
and H are affected similarly by lin-14(lf) and lin-4(lf) suggesting these genes are
regulated independently by lin-14 in the L1 stage and by a lin-4 pathway in the
L2 stage.
b The total number of genes assayed was 11,899.
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(9). The CisOrtho search of the C. elegans genome yielded five
genes (C15C7.5, W09C5.4, T10B9.7, F59B8.2, and F01G10.1)
with upstream matches to a LIN-14 consensus (see Table S3 at
http://banjo.dartmouth.edu/Hristova_etal_Sup/). For three of
these genes (C15C7.5, W09C5.4, and T10B9.7), predicted
LIN-14 sites are also found upstream of the Caenorhabditis
briggsae ortholog, suggesting that these three genes are the
strongest candidates for bona fide LIN-14 targets. By the cri-
teria applied here, W09C5.4 best fits the profile of a gene that
could be regulated in vitro by direct binding of LIN-14;
W09C5.4 mRNA is (i) L2-specific in the wild type (19), (ii)
up-regulated in lin-14(lf) L1 larvae and down-regulated in lin-
4(lf) L2 larvae, and (iii) contains conserved LIN-14 consensus
binding sites in its upstream sequences. For these reasons we
used W09C5.4 to test the hypothesis that LIN-14 can regulate
gene expression in vivo by DNA binding.
W09C5.4 encodes a developmentally regulated insulin/insu-
lin-like growth factor (IGF) homolog, ins-33. W09C5.4 en-
codes a predicted protein of 124 amino acids that is homolo-
gous to members of the C. elegans-specific alpha group of
insulin/IGF-like proteins (40). In our microarray experiments,
W09C5.4 transcripts were at least four times more abundant in
lin-14(lf) L1 larvae compared to wild-type L1 larvae and at
least three times lower in lin-4(lf) L2 larvae compared to wild-
type L2 larvae. These data suggest that W09C5.4 may be an
L2-specific gene that is repressed by lin-14 in the L1 stage of
the wild type. To confirm this supposition, the developmental
profile of ins-33 was examined using Northern blot analysis of
RNA from wild-type larval stages. ins-33 transcripts are absent
in the L1 and then accumulate in the L2 stage (Fig. 3, compare
first and second lanes). In lin-14(lf) L1 animals, ins-33 mRNA
accumulates precociously (Fig. 3, compare third and fourth
lanes). In lin-4(lf) L2 larvae, where LIN-14 levels are abnor-
mally high, ins-33 message is reduced compared to wild type
(data not shown). These results indicate that ins-33 gene ex-
pression is developmentally regulated and that lin-14 nega-
tively regulates ins-33 during the first larval stage.
The ins-33 5 upstream regulatory region confers stage-spe-
cific reporter expression. To determine whether the observed
developmental regulation of ins-33 mRNA is controlled at the
level of transcription, we generated transcriptional reporter
plasmids containing approximately 2 kb of 5 upstream se-
quence from the ins-33 gene (pVT396) or 452 bp of ins-33
upstream sequence (pVT397) fused to GFP (see Fig. S3 at
TABLE 4. Genes whose mRNA levels changed significantly in both lin-4 and lin-14 mutants
Gene a
Delta of lin-14(lf) b Delta of lin-4(lf) c Class d Stage e Phenotype(s) f
UID Locus
C15C7.5 1.00 Down 1.14 Up C U FAT l CLR g GRO g UNC g
F01G10.6 1.01 Down 1.24 Up C U
F41C3.5 1.13 Down 1.06 Up C L1
F31E3.3 rfc-4 1.22 Down 1.17 Up C U EMB g, k, j GRO g STP j
D2096.6 1.54 Down 2.67 Up C L2
C50F2.6 fkb-5 1.70 Down 2.17 Up C L1
C02E7.7 1.72 Down 3.06 Up C U
F53F1.4 1.73 Down 2.07 Up C U
M153.1 1.74 Down 2.28 Up C U
W01F3.3 1.90 Down 2.15 Up C L1 UNC g, l EMB k LVA i
C44H4.3 sym-1 2.04 Down 1.30 Up C L1
F58E6.4 2.98 Up 1.57 Down D U
W09C5.4 ins-33 2.26 Up 2.43 Down D L2 EMB m GRO m UNC m
F44G3.2 1.24 Up 3.61 Down D U
B0412.1a dac-1 1.18 Up 1.62 Down D U TTX o
T10B9.7 cyp-13 1.18 Up 1.54 Down D U
F59B8.2 1.10 Down 1.16 Down G U
C05D9.8/R193.2 1.20 Down 1.19 Down G U GRO g
F01G10.1 1.22 Down 1.07 Down G U CLR g GRO g, h EMB g, h, n LVA h
R08E5.2 1.39 Down 1.39 Down G U
T02B5.3 1.13 Up 1.41 Up H U
a From www.wormbase.org. The genes shown in bold contain putative LIN-14 recognition sites in their 5 upstream sequences (see Table S2 at http://banjo.dart-
mouth.edu/Hristova_etal_Sup/). UID, unique identifier.
b Log 2 of the change (n-fold) in lin-14(lf) L1 stage larvae mRNA expression relative to RNA from wild-type L1 larvae.
c Log 2 of the change (n-fold) in lin-4(lf) L2 stage larvae mRNA expression relative to RNA from wild-type L2 larvae.
d For class, see http://banjo.dartmouth.edu/Hristova_etal_Sup/ (Table S2).
e Stage of greater expression in the wild type (considering only the L1 and L2 stages), based on the results of Hill et al. (19). U, less than twofold difference between
the L1 and L2 stages.
f Abnormalities observed in RNAi experiments of various investigators. EMB, embyronic lethal; GRO, larval growth defects; FAT, defective in fat metabolism; CLR,
clear; STP, sterile progeny; UNC, uncoordinated behavior; LVA, larval arrest; TTX, thermosensing defective. For genes showing no phenotype in RNAi, no description
is given.
g Kamath et al. (23).
h Maeda et al. (32).
i Simmer et al. (52).
j Piano et al. (39).
k Sonnichsen et al. (54).
l Ashrafi et al. (6).
m Fraser et al. (15).
n Rual et al. (47).
o Mutant analysis of Colosimo et al. (12).
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http://banjo.dartmouth.edu/Hristova_etal_Sup/). Each plasmid
was injected into wild-type worms, and stable transgenic lines
were established. Both pVT396 and pVT397 conferred identi-
cal stage-specific and cell type-specific GFP expression. The
transgene carrying pVT397 (maEx172) was used as the basis
for all subsequent experiments.
Faint expression of the maEx172 reporter was observed in
wild-type L1 animals in the head and in one or two cells in the
posterior intestine (Fig. 4A). In contrast to this relative inac-
tivity of the ins-33 promoter in L1 larvae, beginning at the end
of the L1 and continuing during the L2 and later stages, ex-
pression of ins-33::GFP was dramatically up-regulated in the
head and tail hypodermis, the ventral hypodermis, and the
main body hypodermis, hyp-7 (although not in the hypodermal
seam cells) (Fig. 4B). These observations indicate that the 452
bp of the ins-33 upstream region contained in maEx172 can
mediate transcriptional upregulation of ins-33 expression in
hyp-7 after the L1 stage of the wild type.
Stage-specific expression of ins-33::GFP is regulated by lin-
14. The stage-specific expression of GFP under the control of
ins-33 upstream regulatory sequences is consistent with the
observed ins-33 mRNA levels (Fig. 3), which start accumulat-
ing in RNA samples of wild-type L2 larvae. Northern analysis
had revealed that in a lin-14(lf) mutant, endogenous ins-33
mRNA appears precociously during the L1 stage (Fig. 3). To
determine if the stage-specific regulation of ins-33 mRNA de-
tected in Fig. 3 reflects regulation of ins-33 promoter activity,
the ins-33::GFP promoter fusion transgene (maEx172) was
crossed into lin-14(n179ts). These maEx172 lin-14(n179) ani-
mals were raised at the permissive (15°C) or nonpermissive
(25°C) temperature for lin-14(n179) function. L1 larvae raised
at the permissive temperature showed the usual faint L1 ex-
pression of maEx172 typical of wild-type larvae (see above). By
contrast, L1 larvae raised at 25°C exhibited GFP expression in
the hypodermis (Fig. 4C) at levels similar to wild-type L2
larvae. Thus, based on Northern analysis of endogenous ins-33
mRNA (Fig. 3) and the expression of ins-33::GFP (Fig. 4), we
conclude that lin-14 functions via ins-33 upstream sequences to
repress transcription of ins-33 in the hypodermis of L1 larvae.
Bacterially expressed LIN-14 binds specifically to two sites
in the ins-33 upstream sequences. The above results indicate
that lin-14 regulates ins-33 expression at the level of transcrip-
tion. This regulation could occur directly, through direct bind-
ing of the LIN-14 protein to ins-33 regulatory sequences in the
DNA, or indirectly, by the binding of LIN-14 to another pro-
tein or gene that in turn regulates the ins-33 promoter. LIN-14
is a novel protein, and hence its structure does not easily allow
prediction of biochemical function. However, evidence in favor
of a hypothetical direct DNA binding activity for LIN-14
comes from its nuclear localization (50) and our findings (de-
scribed herein) that bacterially expressed LIN-14 can bind
double-stranded DNA and can select a specific binding site via
SELEX. To test if LIN-14 protein can directly bind to ins-33
upstream sequences, we performed EMSA using bacterially
expressed LIN-14 and ins-33 upstream DNA. The fusion pro-
tein 6HIS::LIN-14(284–465), which contains a fragment of
LIN-14 that is sufficient to rescue lin-14 function (20) (Fig. 1A),
was incubated with an end-labeled 452-bp ins-33 DNA frag-
FIG. 3. Northern blot analysis of ins-33 mRNA levels in poly(A)-
selected RNA from wild-type or lin-14(lf) mutant animals at the indi-
cated stages that had been grown at the indicated temperatures.
mRNA samples from either wild-type (lanes 1 to 3) or lin-14(lf) (lane
4) animals, which were grown at either 20°C (lanes 1 and 2) or 25°C
(lanes 3 and 4), were run on a formaldehyde-agarose gel and trans-
ferred onto a nylon membrane. The membrane was probed for ins-33
message (upper panel) and eIF4a (lower panel) as a loading control
(46). ins-33 mRNA displays stage-specific expression in wild-type an-
imals: low or absent message in L1 animals and high transcript levels
in L2 animals. The ins-33 mRNA level is elevated in the L1 stage in the
absence of lin-14 (compare lane 4 to lane 3).
FIG. 4. ins-33::GFP expression in the hypodermis is stage specific
and is controlled by lin-14. (A) Wild-type L1 larvae. GFP expression is
relatively low throughout the animal. (B) Wild-type L2 larva. The most
striking expression of the GFP reporter is observed in the hypodermis
after the L1 stage. Expression is excluded from the seam cells (thick
arrows), which can be seen as dark areas. Expression can be observed
in hypodermal cells in the head and tail (not shown), as well as in the
main body hypodermal synctium, hyp-7, shown here (thin arrows in-
dicate hyp-7 nuclei). (C) lin-14(lf) L1 larva. Precocious expression of
ins-33::GFP is observed throughout the hypodermis, in a pattern sim-
ilar to that of wild-type L2 larvae (compare with panel B).
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ment (see Fig. S3 at http://banjo.dartmouth.edu/Hristova_etal
_Sup/) corresponding to the sequence that we found to confer
lin-14-dependent expression of a GFP reporter in transgenic
worms (Fig. 4). LIN-14 protein bound to the 452-bp DNA
fragment, resulting in a species of altered electrophoretic mo-
bility (Fig. 5A, lanes 2 to 6). At higher protein concentrations,
an apparent aggregate between the protein and DNA is evi-
dent (Fig. 5A, lane 7). To further delineate the location of
LIN-14 binding, a shorter fragment (see Fig. S3 at http://banjo
.dartmouth.edu/Hristova_etal_Sup/) of 365 bp was tested. This
fragment also shifted in the presence of LIN-14 protein
(Fig. 5B, lane 2). The binding was due specifically to LIN-14
protein, as the addition of anti-LIN-14 antibody to the binding
reaction caused a supershift of the probe (Fig. 5B, lane 3),
while addition of preimmune serum had no effect (Fig. 5B,
lane 4).
To more precisely map the LIN-14 binding site(s), we per-
formed DNase I footprinting. In the presence of 6HIS::LIN-14-
(284–465), two sites within either the 452-bp fragment (not
shown) or the 365-bp fragment (Fig. 5C) were protected from
digestion. The specific regions protected were mapped more
precisely using shorter fragments of DNA (not shown), and the
sequences of the approximately 15-bp regions protected is
shown in Fig. 5C. The two regions are referred to as “proxi-
mal” and “distal” in reference to their location with respect to
the ins-33 translation start site. Alignment of the two se-
quences revealed the common core G(TT/AA)C, which is
identical to the core consensus sequence identified through
PCR-assisted binding site selection (Fig. 2B).
These results indicate that the LIN-14 protein can directly
bind to at least two sites in the ins-33 upstream regulatory
region. Moreover, the presence of identical nucleotides found
at the core of each protected sequence strongly suggests that
these nucleotides are required for binding of LIN-14 to the
DNA. To test this hypothesis, we introduced mutations at six of
the positions in the proximal protected element (Fig. 6A).
EMSA assays using 50-bp oligonucleotides with sequences
FIG. 5. LIN-14 directly binds ins-33 upstream sequences in vitro.
(A and B) EMSAs. Bacterially expressed 6HIS::LIN-14(284–465)
(Fig. 1A) was bound to end-labeled fragments of the ins-33 pro-
moter (see Fig. S3 at http://banjo.dartmouth.edu/Hristova_etal_Sup/).
(A) Protein-DNA complexes formed between 6HIS::LIN-14(284–465)
(8 to 320 nM) and a labeled 452-bp fragment of ins-33 upstream
sequences. The super-retarded smeared signal formed at 320 nM
6HIS::LIN-14(284–465) (lane 7) may represent an aggregate too large
to be resolved properly on the gel. (B) Protein-DNA complexes
formed between 6HIS::LIN-14(284–465) (40 nM) and labeled 365-bp
fragment of the ins-33 upstream sequence. Addition of anti-LIN-14
antibody (lane 3) further retards the mobility of the bound material;
mobility is unaffected by the addition of preimmune serum (lane 4).
(C) LIN-14 protects two sites in the ins-33 promoter from DNase I
digestion. The 365-bp fragment of the ins-33 promoter was end labeled
at the 3 end and incubated with a molar excess of 6HIS::LIN-14(284–
465). Lanes 1 and 4 are samples where no LIN-14 was added, while
lanes 2 and 3 are samples with increasing concentrations of excess
6HIS::LIN-14(284–465). The DNA was partially digested with DNase I and
fragments were separated on a sequencing gel. Two sites are protected
from DNase I digestion in the presence of 6HIS::LIN-14(284–465);
these sites are referred to as proximal and distal, indicating their
relationship to the predicted translation start site. An alignment of the
two protected sequences shows a core of four nucleotides shared by the
two sequences and identical to the core consensus binding site deter-
mined for LIN-14 in vitro (Fig. 2B).
FIG. 6. Bacterially expressed LIN-14 binds a fragment of the ins-33
promoter containing the wild-type LIN-14 consensus binding site but
does not bind a fragment containing a mutated binding site. (A) The
wild-type proximal LIN-14 binding site or the indicated mutant se-
quence (mutated sequence boxed) was included in 50-bp double-
stranded DNA oligonucleotides used in gel shift assays with purified
6HIS::LIN-14(284–465) protein. (B) 6HIS::LIN-14(284–465) binds the
wild-type fragment of ins-33 promoter (compare lanes 1 and 2). This
binding requires the presence of a wild-type core consensus and sur-
rounding sequences, as the mutated fragment did not compete for
binding to LIN-14 (compare lanes 2 and 3 with lanes 4 and 5). Lanes
3 and 5 have a 50 molar excess of unlabeled competitor; lanes 4 and
6 have a 200 molar excess of unlabeled competitor. LIN-14 did not
bind a fragment of the ins-33 promoter containing the mutated se-
quences shown in panel A (compare lanes 7 and 8 with lanes 1 and 2).
The wild-type and mutant competitors in lanes 9 and 10 were present
at a 50 molar excess.
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containing the wild-type or mutated proximal protected ele-
ment were performed to test binding specificity. The 6HIS::LIN-
14(284–465) protein bound the oligonucleotides containing the
wild-type but not the mutated sequence (Fig. 6B, compare
lanes 2 and 8). Moreover, the mutated sequences did not
compete away the binding between 6HIS::LIN-14(284–465)
and the wild-type sequences (Fig. 6B, lanes 5 and 6), whereas
the wild-type sequence did (Fig. 6B, lanes 3 and 4). These
results support the conclusion that LIN-14 can bind specifically
to two sequences in the ins-33 upstream regulatory region and
that residues in the core sequence G(TT/AA)C, possibly in
conjunction with residues outside the core, are necessary for
this binding.
Stage-specific regulation of ins-33::GFP by lin-14 requires
wild-type sequences in the two LIN-14 binding sites. The
6HIS::LIN-14(284–465) fusion protein was found to bind two
sites within 452 bp of the ins-33 upstream regulatory sequence
in vitro. To test if the binding sites are important for the lin-14
repression of ins-33::GFP hypodermal expression in the L1, we
engineered the mutations described above (Fig. 6A) into both
putative LIN-14 binding sites in the 452-bp upstream region in
pVT997, creating pVT997mut (Fig. 7A). Wild-type and mutant
constructs were injected into lin-14(n179ts) animals, and stable
transgenic lines were established containing either the wild-type or
the mutant transgene. At 15°C, which is the permissive tem-
perature for lin-14(n179ts), two independent lines carrying the
mutant upstream sequences showed precocious expression of
GFP during the L1 stage (Fig. 7B and C). This result indicates
that the mutant promoter is substantially resistant to repres-
sion by lin-14. In contrast, the wild-type transgene was not
expressed in lin-14(n179ts) L1 larvae at 15°C (Fig. 7C) but was
expressed when worms were grown at the nonpermissive tem-
perature for lin-14 (25°C) (data not shown).
These results indicate that the repression of ins-33::GFP
expression in the L1 stage requires lin-14 activity and also
requires the presence of functional LIN-14 binding sites in the
ins-33 upstream regulatory region. We therefore conclude that,
at least in the case of ins-33, LIN-14 appears to repress tran-
scription by directly binding to a specific recognition sequence
within 5 regulatory sequences.
DISCUSSION
DNA binding activity of LIN-14. Several findings suggest
that chromatin association and DNA binding, in particular, are
important for LIN-14 function in vivo. First, although LIN-14
is a novel protein, a carboxy-terminal domain of LIN-14 that is
necessary and sufficient for in vivo function of LIN-14 (20)
contains basic residues and a predicted helical structure con-
sistent with nucleic acid binding (59). Second, we find that this
FIG. 7. An ins-33::GFP transgene carrying mutations in the LIN-14
binding sites is expressed precociously in the hypodermis of L1 larvae.
(A) Wild-type and mutant versions of the 452-bp ins-33 upstream
sequence. The mutant sequence is altered at both the proximal and
distal binding sites (Fig. 4A). (B) An L1 animal expressing ins-33::GFP
from the pVT397mut reporter transgene (top panel). Arrows indicate
hyp-7 nuclei, while the arrowhead points to a nonexpressing seam cell
(also indicated in the differential interference contrast image, lower
panel). (C) Frequency of precocious expression during the L1 stage of
the mutated transgene (for two independent transgenic worm lines,
pVT397mut-a and pVT397mut-b) compared to the wild-type trans-
gene (for two independent lines, pVT397-a and pVT397-b). All four
lines are of genotype lin-14(n179ts), and so the animals were grown at
the permissive temperature of 15°C. No animals carrying the wild-type
binding site reporter transgene showed expression of the ins-33::GFP
reporter precociously, while 41% and 71% of animals carrying the
mutant binding site showed precocious ins-33::GFP expression. At
the restrictive temperature (25°C) for lin-14(n179ts), the line carrying
the wild-type promoter showed precocious expression of the reporter
in 71% of animals (not shown). n, number of larvae scored.
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LIN-14 carboxy-terminal domain, when expressed in bacteria,
can bind double-stranded DNA in vitro, indicating that LIN-14
could indeed function in vivo by direct DNA binding. This
LIN-14 carboxy-terminal domain also bound single-stranded
DNA. Other nuclear proteins, such as RPA and p53, have been
shown to bind both double- and single-stranded DNA (55, 57,
58). LIN-14 might possess both double-stranded binding and
single-stranded DNA binding activities in vivo, or the single-
stranded binding activity of the carboxy-terminal domain that
we tested may represent a relaxed substrate specificity caused
by the absence of amino terminal sequences.
Further evidence in support of a DNA binding activity for
LIN-14 in vivo is our finding that LIN-14 exhibits sequence
specificity of DNA binding in vitro. We performed a PCR-
based binding site selection assay (SELEX) and recovered the
putative consensus GAACRY (complement, RYGTTC). This
consensus sequence does not appear to match previously
known transcription factor binding sites, suggesting that our
results identify LIN-14 as a transcriptional regulatory factor of
novel sequence specificity.
Also in support of in vivo DNA binding by LIN-14 is the
apparent chromatin association of endogenous full-length
LIN-14 and LIN-14::GFP fusion protein. We found that a
small fraction of endogenous LIN-14 is released from the bulk
of chromatin by digestion of worm nuclei with MNase (see
Fig. S1 available at http://banjo.dartmouth.edu/Hristova_etal
_Sup/). For LIN-14::GFP fusion proteins, the evidence for
functional interaction with chromatin is from a correlation
between the in vivo rescuing activity of the transgenes and the
association of the corresponding fusion proteins with mitotic
chromosomes (Fig. 1). Other proteins known to interact di-
rectly with DNA and that also interact with condensed mitotic
chromatin include ATRX (8) and the C. elegans SMAD, daf-3
(38). By contrast, some DNA binding proteins such as Sp1 and
HSF1 appear to be excluded from mitotic chromatin (refer-
ence 33 and references therein). Although we find that mitotic
chromosome association correlates with function for trun-
cated, overexpressed forms of LIN-14::GFP, the endogenous
LIN-14 protein was not detected in association with metaphase
chromosomes (data not shown). Accordingly, we interpret the
mitotic chromatin binding behavior of the LIN-14 carboxy-
terminal domain to represent a low-affinity activity of the na-
tive LIN-14, which is not detected unless the protein is present
at abnormally abundant amount.
Evidence supports the idea that the association of LIN-14
with DNA and/or chromatin may not represent the only in vivo
activity of LIN-14. In particular, we found that a significant
fraction of LIN-14 in worms is tightly bound to nuclei, perhaps
in association with the nuclear matrix (see Fig. S2 at http:
//banjo.dartmouth.edu/Hristova_etal_Sup/), and at least some
of the LIN-14 released from nuclei by MNase digestion ap-
peared to sediment apart from polynucleosomes (see Fig. S1 at
http://banjo.dartmouth.edu/Hristova_etal_Sup/). Perhaps LIN-14
exists in distinct pools in normal nuclei. We propose that one
nuclear pool of LIN-14 functions to regulate developmental
timing and is in equilibrium between chromatin-bound and
chromatin-unbound fractions and that another pool is tightly
bound (likely matrix associated). Our results suggest that nu-
clear matrix association may be secondary to the primary func-
tion of LIN-14. In particular, we observed that a truncated
LIN-14::GFP fusion protein that can rescue lin-14 hetero-
chronic mutant phenotypes in the hypodermis nevertheless is
quantitatively eluted from nuclei with low-salt incubation.
Thus, this LIN-14 variant with virtually no detectable nuclear
matrix binding still retains at least partial function. We there-
fore conclude that the pool of LIN-14 strongly associated with
the nuclear matrix in vivo does not participate directly in the
regulation of gene expression, at least not in hypodermal cells,
and may serve as a reservoir of LIN-14 that could be recruited
for function in some physiological or developmental circum-
stances. It remains to be determined whether the loosely
bound and tightly bound nuclear pools of LIN-14 are normally
both found within the same individual nucleus and, if so,
whether there is dynamic interchange among them.
LIN-14 is a transcription factor. The assignment of tran-
scription factor activity to LIN-14 is based on (i) its apparent
chromosome association in vivo, (ii) its in vitro DNA biding
activity and, in particular, (iii) its functional and biochemical
relationship to a canonical LIN-14 target, ins-33. Several char-
acteristics of ins-33 suggest that ins-33 is a direct transcrip-
tional regulatory target of LIN-14 during worm development.
First, the ins-33 mRNA is developmentally up-regulated at the
L2 stage of wild-type development (Fig. 3) (19), consistent with
repression by LIN-14, which is high in the L1 stage and re-
duced in L2. Second, the level of ins-33 mRNA is dramatically
elevated in the L1 stage of animals lacking lin-14 (Fig. 3 and
Table 4) and is reduced in the L2 of animals with elevated
LIN-14 [lin-4(lf)] (Table 4). Third, the stage-specific expression
of ins-33 mRNA in the wild type and its behavior in lin-14(lf)
animals are recapitulated by a reporter transgene containing
452 bp of the ins-33 upstream region (Fig. 4). Since this 452-bp
region contains no ins-33 coding sequence, these results indi-
cate that ins-33 stage-specific expression and the regulation of
ins-33 by lin-14 result from transcriptional regulation via the
452-bp upstream sequence. Finally, two specific sequences
within this 452-bp sequence are protected from DNase I di-
gestion in the presence of purified LIN-14 protein (Fig. 5);
these sequences are necessary for LIN-14 binding to the ins-33
452-bp region in vitro (Fig. 6) and for lin-14-dependent tran-
scriptional repression in vivo (Fig. 7). Taken together, these
results provide strong evidence that LIN-14 is a direct repres-
sor of ins-33 transcription in wild-type worms.
Sixteen putative lin-14 targets. Because our objective has
been to test the hypothesis that LIN-14 is a transcription fac-
tor, we applied strict criteria to identify a high-confidence
candidate target to use as a test case. Therefore, we have not
attempted to comprehensively catalog LIN-14 targets. The
genes we identified by microarray hybridization as lin-14-re-
sponsive undoubtedly include direct targets as well as indirect
targets. It is also quite likely that we may have missed numer-
ous targets in our microarray screens for lin-14-responsive
genes. One reason could be that a target might be broadly
expressed in the animal but regulated by lin-14 in only a subset
of cells. An example is cki-1 (T05A6.1), which has been shown
to be regulated by lin-14 in the vulva precursor cells (VPCs)
(21). By our microarray assays, cki-1 mRNA was essentially
unchanged in lin-14(lf) and lin-4(lf). This is most likely because
cki-1 is expressed in diverse cell types besides the VPCs, while
the VPCs are the only cell type were cki-1 expression is affected
by lin-14 mutations (21).
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A key criterion for classifying genes as potential LIN-14
direct targets was the occurrence of a sequence fitting the
consensus LIN-14 site derived by SELEX. Five of the 16 genes
contain a good match to a 12-nucleotide consensus derived
from the SELEX data. However, the sequence specificity of
LIN-14 binding has not been explored in detail, and so the
stringent consensus that we used to search for sites may not
encompass all bona fide LIN-14 sites. Many of the 16 predicted
target genes contain core G(AA/TT)C sequences in their up-
stream sequences and, hence, could be targets with sites that
more loosely fit the search consensus (for sites see Table S2 at
http://banjo.dartmouth.edu/Hristova_etal_Sup).
If the genes listed in Table 4 are bona fide lin-14 targets, how
might they be involved in cell fate decisions controlled by lin-14
in L1 versus L2? The lin-14 mutations affect a diverse set of
cells and cellular behaviors, including the hypodermal cell di-
vision pattern, intestinal cell cycle behavior, neuroblast identity
(1), neuronal polarity (17), dauer larva arrest (30), and VPC
cell cycle (21). The precise nature of the cellular behaviors
controlled by lin-14 depends on cell type, and so it is reason-
able to expect that LIN-14 may repress or activate target genes
in a cell type-specific manner. Among the 16 high-probability
LIN-14 targets listed in Table 4, only one, B0412.1, encodes a
predicted transcription factor, suggesting that lin-14 does not
chiefly function by regulating the expression of other transcrip-
tion factors. None of the putative lin-14 targets in Table 4 has
been shown to have a loss-of-function heterochronic pheno-
type. Several of these candidate targets have RNAi phenotypes
that include general growth problems, suggesting that these
genes function in one or more essential cellular processes. But
since their phenotypes are not simply developmental timing
defects as with lin-14(lf) or lin-4(lf), it would appear that the
products of these genes may function as effectors of the cellular
behaviors whose timing is controlled by lin-14.
The ins-33 gene and the function of lin-14 in developmental
timing. The evidence presented here strongly suggests that
stage-specific expression of ins-33 in hypodermal cells of wild-
type worms is controlled by LIN-14 on the level of transcrip-
tion, suggesting a role for lin-14 as a transcription factor con-
trolling the timing of an L2-specific insulin/IGF signal. One
developmental event that is known to be regulated by both
lin-14 and by insulin signaling in C. elegans is the expression of
the optional third larval stage, the dauer larva. Dauer larvae
are developmentally arrested and specialized larvae formed in
crowded or starved cultures. In wild-type worms, dauer larva
formation can occur only at the L2 molt. The lin-14 loss-of-
function mutations affect the timing of dauer formation, in-
cluding the execution of the dauer remodeling program by the
hypodermis (30). lin-14(lf) animals can become dauer larvae
precociously, at the end of the L1 stage; moreover, they form
partial dauer larvae, where the hypodermis does not remodel
properly in patches of the animal. The animal’s decision to
arrest development as a dauer larva is controlled by at least
two environmental signaling pathways: a transforming growth
factor  cascade, which detects a worm-specific pheromone
and thus responds to crowding, and an insulin/IGF cascade,
which likely reflects the metabolic state of the animal and thus
responds to nutrient availability (44). Since dauer larva devel-
opment is in part controlled by insulin signaling, ins-33 could
function to couple the dauer larva program to temporal sig-
nals. Thirty-seven insulin-related ligands have been predicted
in the worm, compared to three in vertebrates (40). DAF-2 is
the C. elegans homolog of the insulin and IGF-1 receptors from
vertebrates (24). It appears that daf-2 can mediate different
insulin signals for different life history events; for instance,
overexpression of ins-1 affects dauer formation, larval growth,
and longevity, while overexpression of ins-9 and ins-31/19 af-
fects larval growth but not dauer formation or longevity (40). It
is possible that daf-2 also mediates different insulin signals in
different cell types. These signals would then collaborate to
influence the dauer arrest decision. This collaboration hypoth-
esis is consistent with the finding that, for dauer development,
daf-2 functions cell nonautonomously in a number of tissues,
including neurons and hypodermis (4). The precise expression
pattern of daf-2 has not been reported. Perhaps ins-33 is the
insulin signal or one of the insulin signals from the hypodermis,
which contribute(s) to the final dauer larva initiation decision.
A phenotype was previously reported for ins-33 loss-of-func-
tion by RNAi (15). The phenotype included embryonic lethal-
ity and slow-growing and uncoordinated larvae. The authors
did not report heterochronic or dauer-related phenotypes.
However, the original RNAi bacterial strain used in the study
by Fraser et al. (15) has been lost (J. Ahringer, personal com-
munication), and we did not observe an ins-33 phenotype in
our own RNAi experiments (data not shown). Since a negative
result in RNAi experiments could reflect factors other than the
actual requirement for the gene, we cannot say at present
whether ins-33 is required for the normal timing or execution
of dauer larva development. It is possible that lin-14 controls
the timing of dauer larva development through the regulation
of ins-33 transcription in concert with another, redundant
factor.
Complexity of regulatory pathways involving lin-14 and
lin-4. If lin-14 were the only target of the microRNA product of
lin-4, then one simple expectation would be that all the genes
affected by lin-14(lf) should be reciprocally affected by lin-4(lf).
Genetic analysis has shown that mutations in lin-14 are epi-
static to lin-4(lf) (1), which would suggest that most, and per-
haps all, of the lin-4(lf) phenotype depends on lin-14 activity.
However, our results described here suggest that the lin-4/
lin-14 pathway is more complex than the simplifying expecta-
tion, and may diverge significantly. For example, we observed
that numerous genes were significantly altered in lin-4(lf) that
were unaffected in lin-14(lf) mutants (Table 3). These genes
could include bona fide lin-14 targets that respond to LIN-14
levels in the L2 stage but are independent of lin-14 in the L1
stage. However, lin-4 microRNA is known to have at least one
other target, lin-28 (36), which encodes an RNA binding pro-
tein that could regulate mRNA levels posttranscriptionally.
Many of the genes affected by lin-4(lf) and not by lin-14(lf) in
our microarray experiments, indeed, may not be targets of
LIN-14 but, rather, could be regulated by lin-4 via lin-28 or
other unidentified targets of lin-4.
Some bona fide LIN-14 target genes could be among the
genes that did not respond reciprocally to lin-14(lf) and lin-
4(lf). In particular, genes of classes A and B (Table 3) changed
in the lin-14(lf) microarray experiments but were not affected
by lin-4(lf). For many of these genes, expression might have
been altered as an indirect consequence of the physiology of
the lin-14(lf) mutant. Others could be direct LIN-14 targets
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whose expression is activated by LIN-14 in the L1 stage but
becomes governed by other factors in the L2 stage (rendering
them insensitive to removal of lin-4).
The results reported here establish that LIN-14 likely regu-
lates the timing of developmental events through the direct
binding to specific recognition sequences of diverse target
genes. Down-regulation of LIN-14 levels from the L1 to the L2
stage likely results in the derepression of genes, such as ins-33,
that are negatively regulated by LIN-14. It remains to be de-
termined whether most LIN-14 target genes are repressed by
LIN-14 binding or whether LIN-14 can also activate transcrip-
tion in some situations. LIN-14 presumably acts in combina-
tion with cell type-specific transcriptional regulators to affect
repression or activation of target genes in conjunction with
regulating L1 and L2 developmental programs. A complete
understanding of how the lin-4/lin-14 circuit regulates diverse
developmental events in C. elegans larvae will require a com-
prehensive catalog of all the genes targeted by LIN-14 in vivo;
knowledge of where, when, and how they are affected by lin-14
activity; and genetic analysis of their functional relationships
to lin-14.
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